Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2GS5D8
Fri, 28.03.2025
Dermapharm Holding SE
Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance
Consolidated revenue up 4.0% to EUR 1,180.8 million
(Unadjusted) consolidated EBITDA increases by 10.2% to EUR 308.9 million, unadjusted EBITDA margin at 26.2%
(Adjusted) EBITDA of EUR 315.6 million produces adjusted EBITDA margin of 26.7%; adjustments d [ … ]
Fri, 14.03.2025
Dermapharm Holding SE
Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA
Consolidated revenue up 4.0% to EUR 1,180.8 million, driven by strong organic growth in the "Branded pharmaceuticals" segment
Above-average increase in unadjusted consolidated EBITDA by 10.2% to EUR 308.9 million, unadjusted EBITDA margi [ … ]